Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors. - Wikidata - wikimedia - TriplyDB

Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.

Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.

http://www.wikidata.org/entity/Q33891952

about

Smart nanosystems: Bio-inspired technologies that interact with the host environment High-Throughput Approaches to the Development of Molecular Imaging Agents.Radiation-induced tumor neoantigens: imaging and therapeutic implications.Quantitative analysis of nanoparticle internalization in mammalian cells by high resolution X-ray microscopy A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells.High-throughput identification of putative receptors for cancer-binding peptides using biopanning and microarray analysis.Combinatorial peptide libraries: mining for cell-binding peptides.Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.Radiation-guided drug delivery to mouse models of lung cancer Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.Nanomedicine as an emerging approach against intracellular pathogens Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach."OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.Tumor-targeting peptides from combinatorial libraries.Virtual interactomics of proteins from biochemical standpoint.Engineering dextran-based scaffolds for drug delivery and tissue repair.Retargeted adenoviruses for radiation-guided gene delivery.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.Nanosponge formation from organocatalytically-synthesized poly(carbonate) copoplymers RNA interference in the clinic: challenges and future directions.Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment.The combination of chemotherapy and radiotherapy towards more efficient drug delivery.Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma.Self-assembling dual component nanoparticles with endosomal escape capability.Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.A programmable sensor to probe the internalization of proteins and nanoparticles in live cells.Design of degradable click delivery systems.Circulating GRP78 antibodies from ovarian cancer patients: a promising tool for cancer cell targeting drug delivery system?Biofilm dispersal using nitric oxide loaded nanoparticles fabricated by photo-PISA: influence of morphology.Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma.In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.

P2860

Q26776370-7D1D46FC-2FC7-4D39-8B0A-B08109BDCB53 Q30275493-B9023A87-8B27-4643-9959-B6F07EA72884 Q30473856-6FCE6091-05C4-4A1B-9C61-C7627804F95E Q30500321-AF36A75B-BDB7-41B5-8410-99B2C58BA005 Q30501296-025D3520-EFB3-4562-ADC9-A01780C5617E Q31106868-CCE919CC-4F5C-428C-86D6-278AABADD397 Q31144876-30EC5993-0059-462F-98E0-EEA8AC745A94 Q33746121-55AD28A8-92A2-4258-84D6-DC9F693746FF Q34204251-5D037260-40A7-4583-8998-8EC6282FAF46 Q34953629-B5634021-F670-4A40-AF03-B2C742EC7096 Q35061044-54246631-8E7A-40AE-AE89-4E664C0E1664 Q35090829-FE10464F-0A40-4FF6-BEE1-8F77529F03F6 Q35432445-26006064-60BB-469C-8AC3-EC46B466BE11 Q35656908-F06610E3-ADA6-4EFA-8BA2-6037DC228DFF Q35691410-5EE4BA82-6F6E-49C7-9D6D-5087A9512161 Q35864578-923C538D-0530-43FE-B772-6363E1CA7686 Q35932503-D83901AA-6169-4DF7-939B-7E9C2D22281F Q36025723-C37CB7E6-D769-4872-AEA1-263A2DA4EEBE Q36178385-A7FC09ED-C5A2-48D1-A11A-A7F168406475 Q36205757-7E192EC8-0E02-4894-9057-5502BCB601DB Q37273145-81B72532-0085-4ABE-835A-C67C1D38A123 Q37422972-E5ADA623-DD9F-430D-874B-C092F56E0513 Q37449406-0F0F2AEC-B3E0-4242-AE5C-924B8B1579BE Q37600688-FC1E943A-4634-4D9E-A007-1276A04BD96D Q37692022-D784C292-8BDF-456F-8BC5-5849B1801EBF Q37821230-C5009A12-FFC8-456B-8956-998BDE025D09 Q38032893-C4CACB7E-CC8B-4C4F-960B-9A3BA4BB5779 Q38067265-779FAB1C-6D5A-4AB7-95C6-1F62B998D3A6 Q38081028-3AC6F492-440D-4E85-A6AF-50F9E37A2A6D Q38172027-5A51325D-A2E2-47A0-8F02-8B7F774813AB Q38198491-6F572A1D-158E-4D6E-B644-C683185F64E9 Q39627791-AD1CF612-C4C9-47E2-9505-FA29F80214DF Q42829866-A3AEDE00-A003-4DA8-B0E8-8473152CD010 Q46134516-BE35F9B0-7A77-4585-B978-5711EB99B697 Q46312134-6F6ABF64-AAFE-4DD2-8701-45FA7D31A3E9 Q46862086-962FAAF5-24C3-4E2F-ADB2-CA68DAA42723 Q47241108-F28BD881-6B95-4986-9811-FDAD42D0BC68 Q47327515-753BE6C4-7664-42CA-86E8-667F61970717 Q47655685-CA354BF3-7A6F-4F2F-A783-ECAC6979F7B6 Q50914810-0EF29DCF-1943-4CDA-8081-0DB86C46FA20

P2860

Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.

http://www.wikidata.org/entity/Q33891952

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@ast

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@en

type

label

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@ast

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@en

prefLabel

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@ast

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@en

P1433

Q33891952-65A524F3-E445-443F-A27C-C0B6EF84F933

P1476

Q33891952-7FF36996-171A-41A2-BF41-2B22CC6189D3

P2093

Q33891952-2A194AF9-A419-49E0-8998-C795718D05FE

Q33891952-3852BC96-E4F8-4EE5-AED8-BD7440220DBD

Q33891952-9DBC24BD-B603-466A-8982-CCEF8059216B

Q33891952-A17BD014-92B3-45E6-B5DA-FB42DF24675D

Q33891952-CC79C332-052F-4593-8AAD-06E4347C5AC2

Q33891952-D224828D-67BE-46FC-9AAF-080E11611F45

Q33891952-DE4674A1-98A0-48D3-AA3F-FAC425C94E83

Q33891952-EF28ABC6-EC03-4EDB-945A-A5B23770B3A9

Q33891952-EF6E44A4-FC1F-4F25-BFE0-3692E7063BA5

Q33891952-F8CA1D04-34B5-4BFA-8AD7-F619CF9518D6

P2860

Q33891952-13829491-2786-40DC-A030-6619E476D387

Q33891952-1EAB6716-4C62-478F-8A01-F903091F4984

Q33891952-1ECBE0AD-D832-4C80-BDE6-43A2DC6EB8B1

Q33891952-2307B105-D7B4-4C39-9897-1FF5F707FE93

Q33891952-3CDD05C3-885B-44D1-ACEC-80BB5BCE92AF

Q33891952-4FC11F30-89DA-4299-B847-EF6015BF1329

Q33891952-50270691-633B-4E06-A7D3-D75B20EB3477

Q33891952-52101ED8-0940-466B-8707-30E4519C4300

Q33891952-55081DD2-4D4D-4348-BCD6-A08547C7AC95

Q33891952-71A9DBED-3623-44C0-9093-AEAA6D2A2113

P304

Q33891952-27A436E7-29D6-4FAE-84CA-D2BF8073009E

P31

Q33891952-0E543A09-84A8-4713-95EA-1CFAC23CABC7

P356

Q33891952-D51B6878-CD50-4A26-9FBA-F480EC53920A

P407

Q33891952-AD5FE41A-78BC-41FF-87B9-951AB03AB434

P433

Q33891952-76B7EB91-3496-43AF-972D-13B2CAF76A51

P478

Q33891952-D293102A-994E-46D2-8397-4D9A786E1780

P577

Q33891952-18D1B6D9-F932-49EB-9F03-4A834AA0842A

P5875

Q33891952-BA5A1F55-4065-487C-B2A2-AE8E3002745B

P698

Q33891952-0FAD1121-7965-40E4-91A0-1FF42C3935AF

P921

Q33891952-48C53986-87EA-468B-B70D-92C7DA8B0B6F

P932

Q33891952-67D9AAF1-960E-41B1-9EF4-B354CC8AAAA3

P356

0008-5472.CAN-10-0339

P1433

Cancer Research

P1476

Targeted nanoparticles that de ...... clitaxel to irradiated tumors.

@en

P2093

Alice E van der Ende

http://www.w3.org/2001/XMLSchema#string

Daniel E Spratt

http://www.w3.org/2001/XMLSchema#string

Dennis E Hallahan

http://www.w3.org/2001/XMLSchema#string

Eva Harth

http://www.w3.org/2001/XMLSchema#string

Hongmei Wu

http://www.w3.org/2001/XMLSchema#string

John G Phillips

http://www.w3.org/2001/XMLSchema#string

Li Zhou

http://www.w3.org/2001/XMLSchema#string

Ralph J Passarella

http://www.w3.org/2001/XMLSchema#string

Roberto Diaz

http://www.w3.org/2001/XMLSchema#string

Vasanth Sathiyakumar

http://www.w3.org/2001/XMLSchema#string

P2860

Radiation-Mediated Gene Expression in the Pathogenesis of the Clinical Radiation Response

Fingerprinting the circulating repertoire of antibodies from cancer patients.

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.

Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.

Determining glioma response to radiation therapy using recombinant peptides.

Novel thermo-sensitive core-shell nanoparticles for targeted paclitaxel delivery.

Recombinant peptides as biomarkers for tumor response to molecular targeted therapy.

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

Dendrimers in biomedical applications--reflections on the field.

P304

4550-4559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-0339

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44612846

http://www.w3.org/2001/XMLSchema#string

P698

20484031

http://www.w3.org/2001/XMLSchema#string

P921

P932

2880200

http://www.w3.org/2001/XMLSchema#string